Hubei Biocause Pharmaceutical Co., Ltd. (SHE: 000627)
2.900
+0.260 (9.85%)
Sep 9, 2024, 1:41 PM CST
Hubei Biocause Pharmaceutical Revenue
Hubei Biocause Pharmaceutical had revenue of 11.57B CNY in the quarter ending June 30, 2024, with 0.88% growth. This brings the company's revenue in the last twelve months to 43.92B, down -20.40% year-over-year. In the year 2023, Hubei Biocause Pharmaceutical had annual revenue of 48.28B, down -2.10%.
Revenue (ttm)
43.92B
Revenue Growth
-20.40%
P/S Ratio
0.33
Revenue / Employee
24.88M
Employees
1,765
Market Cap
14.33B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 48.28B | -1.03B | -2.10% |
Jan 1, 2023 | 49.31B | 614.72M | 1.26% |
Jan 1, 2022 | 48.70B | 7.57B | 18.40% |
Dec 31, 2020 | 41.13B | -8.54B | -17.20% |
Dec 31, 2019 | 49.67B | 19.79B | 66.25% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition